The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effects of body mass index (BMI) on plasma levels of estrone sulfate (ES) in postmenopausal women with breast cancer (BC) during letrozole (L) treatment.
G. Lunardi
No relevant relationships to disclose
L. Del Mastro
Honoraria - Novartis
Research Funding - Novartis
C. Bighin
No relevant relationships to disclose
G. Bisagni
No relevant relationships to disclose
P. Driol
No relevant relationships to disclose
O. Garrone
No relevant relationships to disclose
S. Giraudi
No relevant relationships to disclose
P. Marroni
No relevant relationships to disclose
P. Piccioli
No relevant relationships to disclose
R. Ponzone
Honoraria - Novartis
Other Remuneration - Novartis
M. Porpiglia
No relevant relationships to disclose
M. Venturini
Research Funding - Novartis